13F Filings History of REGENERON PHARMACEUTICALS, INC.

Latest 13F report
Q3 2025 - 07 Nov 2025
Value $
$700,444,832
Signature - Title
Leonard Brooks - Senior Vice President, Treasurer
Location
Tarrytown, NY
Summary
This page shows a list of all the recent 13F filings made by REGENERON PHARMACEUTICALS, INC.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. REGENERON PHARMACEUTICALS, INC. reported 4 stock holdings with total value $700,444,832 as of Q3 2025. Top holdings included ALNY, NTLA, ADVM, and ACET.

Notify me when REGENERON PHARMACEUTICALS, INC. files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2025 4 $700,444,832 $0 -$1,391,776,752 -$1,391,776,752 ALNY, NTLA, ADVM, ACET 13F-HR 07 Nov 2025, 16:55
Q2 2025 4 $1,485,002,709 $0 -$6,301,325 -$6,301,325 ALNY, NTLA, ACET, ADVM 13F-HR 01 Aug 2025, 16:09
Q1 2025 6 $1,234,240,208 $0 $0 $0 ALNY, NTLA, TSVT, ADVM, ACET 13F-HR 02 May 2025, 16:15
Q4 2024 6 $1,094,639,843 $0 $0 $0 ALNY, NTLA, TSVT, ACET, ADVM 13F-HR 07 Feb 2025, 16:36